HubsBaker Botts Represents Underwriters in Offering of Common Units of Westlake Chemical Partners LP
Release
Deal Description: September 26, 2017 - Westlake Chemical Partners LP (NYSE: WLKP) (the “Partnership”) announced that it has priced an underwritten public offering of 4,500,000 common units representing limited partner interests in the Partnership at a price of $22.00 per common unit (before the underwriters’ discount and offering expenses). The Partnership has granted the underwriters a 30-day option to purchase up to an additional 675,000 common units at the public offering price less the underwriting discount. The offering is scheduled to close on September 29, 2017, subject to customary closing conditions.
The Partnership intends to use the net proceeds from this offering, along with borrowings under its revolving credit facility, to fund its obligations under the concurrently announced acquisition of an additional 5.0% limited partner interest in Westlake Chemical OpCo LP (“OpCo”), which will increase the Partnership’s limited partner interest in OpCo to approximately 18.3% (the “OpCo Equity Purchase”). Pending the use of proceeds for such purpose, or if the OpCo Equity Purchase is not consummated for any reason, the Partnership intends to use the net proceeds from this offering for general partnership purposes. OpCo intends to use the proceeds it receives from the OpCo Equity Purchase to repay borrowings under its intercompany debt agreements with Westlake Chemical Corporation.
UBS Investment Bank, Citigroup, Barclays and BofA Merrill Lynch are acting as joint bookrunning managers for the offering.
Baker Botts represented the underwriters in connection with the offering.
Baker Botts Lawyers/Office Involved:
The Partnership intends to use the net proceeds from this offering, along with borrowings under its revolving credit facility, to fund its obligations under the concurrently announced acquisition of an additional 5.0% limited partner interest in Westlake Chemical OpCo LP (“OpCo”), which will increase the Partnership’s limited partner interest in OpCo to approximately 18.3% (the “OpCo Equity Purchase”). Pending the use of proceeds for such purpose, or if the OpCo Equity Purchase is not consummated for any reason, the Partnership intends to use the net proceeds from this offering for general partnership purposes. OpCo intends to use the proceeds it receives from the OpCo Equity Purchase to repay borrowings under its intercompany debt agreements with Westlake Chemical Corporation.
UBS Investment Bank, Citigroup, Barclays and BofA Merrill Lynch are acting as joint bookrunning managers for the offering.
Baker Botts represented the underwriters in connection with the offering.
Baker Botts Lawyers/Office Involved:
- Corporate: Josh Davidson (Partner, Houston); Tim Taylor (Partner, Houston); Carina Antweil (Senior Associate, Houston); Lakshmi Ramanathan (Associate, Houston); Ieuan List (Associate, Houston)
- Tax: Chuck Campbell (Special Counsel, Houston)
- Environmental: Matt Kuryla (Partner, Houston); Ty’Meka Reeves-Sobers (Associate, Austin)
For more information, please see Westlake Chemical Partners LP’s news release.
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm of approximately 725 lawyers practicing throughout a network of 13 offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the technology, energy, and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.
